Cite
HARVARD Citation
Kamal, M. et al. (n.d.). Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment. Clinical pharmacology in drug development. 4 (5), pp. 326-336. [Online].